CLK2 KEAP1/NRF2とp53経路を調節し,大腸がんにおけるフェロプトーシスを抑制する
Hai-Meng Zhou1, Yi Liu2, Feng Shi2
1Wuhan University, Wuhan, Hubei, China.
Cancer research
|August 29, 2025
まとめ
CLK2は,KEAP1/NRF2/HMOX1およびp53/SLC7A11経路を調節することにより,結腸直腸がん (CRC) のフェロプトーシスを抑制する. CLK2をターゲットにすると,フェロプトーシスとCRCの治療効果が向上する可能性があります.
科学分野:
- 腫瘍学
- 細胞 死 の 仕組み
- 分子生物学
背景:
- 鉄に依存する細胞死であるフェロプトーシスは,結腸直腸がん (CRC) の進行と治療に不可欠です.
- 酸化ストレスと鉄を調節するNRF2経路は,HMOX1 (プロフェロプトーシス) とSLC7A11 (アンチフェロプトーシス) のような標的を介してフェロプトーシスに影響を与えます.
研究 の 目的:
- CRCフェロプトーシスにおけるHMOX1とSLC7A11のバランスの調節におけるCLK2の役割を調査する.
- CRCの増殖と腫瘍発生に対するCLK2の影響を調査する.
- CRCの潜在的な治療標的としてCLK2を評価する.
主な方法:
- KEAP1,NRF2,p53,HMOX1,SLC7A11のCLK2の調節を調査した.
- CLK2がCRC細胞,患者由来オーガノイド,マウスモデルに与える影響を評価した.
- CLK2欠乏症のモデルにおけるErastinとOxaliplatinの組み合わせ治療の評価
主要な成果:
- CLK2はKEAP1を安定させ,NRF2の活動を抑制し,HMOX1とSLC7A11をダウンレギュレーションする.
- CLK2はp53を抑制し,SLC7A11の抑制を緩和する.
- CLK2の喪失はHMOX1の過剰活性化につながり,CRC細胞をフェロプトーシスに敏感にし,腫瘍の成長を抑制する.
- CLK2はCRCの増殖と腫瘍発生を促進する.
- エラスティンとオキシリプラチンの併用は,CLK2欠乏症のモデルにおいて,抗腫瘍効果の強化を示した.
結論:
- CLK2は,KEAP1/NRF2/HMOX1およびp53/SLC7A11経路を通じてCRCにおけるフェロプトーシスの重要な阻害剤として作用する.
- CLK2はCRCの増殖と腫瘍発生を促進する.
- CLK2は,フェロプトーシスベースのCRC治療の強化のための有望な治療目標です.
さらに関連する動画
10:13A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
11.3K
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.9K
関連する概念動画
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
Covalently Linked Protein Regulators
7.1K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
7.1K
NF-κB-dependent Signaling Pathway
7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.8K
The Intrinsic Apoptotic Pathway
6.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.8K
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
